Anthony Zampino, MD
- Specialty: Neurology-Neuromuscular Medicine, Neurology
-
Location:UH Lake West Physician Pavillion
36060 Euclid Ave
Willoughby, OH 44094
- Call: 440-918-6860
Biography: Anthony Zampino, MD
Expertise
Certifications & Memberships
- Neurology - American Board of Psychiatry and Neurology
Education
Fellowship | Neuromuscular Disease
Neuromuscular Disease - UH Cleveland Medical Center (2023 - 2024)
Residency | Neurology
Neurology - UH Cleveland Medical Center (2019 - 2023)
Medical Education
Northeast Ohio Medical University (NEOMED) (2019)
Undergraduate
University Of Akron (2014)
About
Anthony Zampino, MD, is an Assistant Professor of Neurology at Case Western Reserve University / University Hospitals Cleveland Medical Center, a neurologist at UH Lake West Medical Center, and a proud Cleveland native.
Dr. Zampino received a Bachelor of Science in biochemistry from the University of Akron before completing medical school at Northeast Ohio Medical University (NEOMED). He then completed his neurology residency at Case Western Reserve University / University Hospitals Cleveland Medical Center, where he also served as chief resident. After his residency, he completed a fellowship in neuromuscular medicine, which is his current specialty.
Dr. Zampino is involved in the clinical education of medical students, residents and fellows. He has a special interest in the use of neuromuscular ultrasound to enhance traditional electrodiagnostic testing and research for autoimmune neuropathies such as Guillain-Barré syndrome (GBS), as well as exploring its use in clinical trials for chronic inflammatory demyelinating polyneuropathy (CIDP).
Research & Publications
Research Interests
Autoimmune neuropathies including new therapeutics for CIDP, neurophysiology, and autonomic dysfunction in Guillain-Barré syndrome | Neuromuscular ultrasound
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Anthony Zampino did not disclose any Outside Relationships with Industry.